For CYP1B1 rs162558, homozygosity was associated with increased CRC risk, and for CYP1A2 rs2069522 heterozygosity was associated with risk, although these associations were not significant after correction for multiple testing. This evidence concerns the gene CYP1A2 and colorectal carcinoma.